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Abstract
Background: While acute lung injury (ALI) contributes significantly to critical illness, it resolves spontaneously in many
instances. The majority of patients experiencing ALI require mechanical ventilation. Therefore, we hypothesized that
mechanical ventilation and concomitant stretch-exposure of pulmonary epithelia could activate endogenous pathways
important in lung protection.
Methods and Findings: To examine transcriptional responses during ALI, we exposed pulmonary epithelia to cyclic
mechanical stretch conditions—an in vitro model resembling mechanical ventilation. A genome-wide screen revealed a
transcriptional response similar to hypoxia signaling. Surprisingly, we found that stabilization of hypoxia-inducible factor 1A
(HIF1A) during stretch conditions in vitro or during ventilator-induced ALI in vivo occurs under normoxic conditions.
Extension of these findings identified a functional role for stretch-induced inhibition of succinate dehydrogenase (SDH) in
mediating normoxic HIF1A stabilization, concomitant increases in glycolytic capacity, and improved tricarboxylic acid (TCA)
cycle function. Pharmacologic studies with HIF activator or inhibitor treatment implicated HIF1A-stabilization in attenuating
pulmonary edema and lung inflammation during ALI in vivo. Systematic deletion of HIF1A in the lungs, endothelia, myeloid
cells, or pulmonary epithelia linked these findings to alveolar-epithelial HIF1A. In vivo analysis of
13C-glucose metabolites
utilizing liquid-chromatography tandem mass-spectrometry demonstrated that increases in glycolytic capacity,
improvement of mitochondrial respiration, and concomitant attenuation of lung inflammation during ALI were specific
for alveolar-epithelial expressed HIF1A.
Conclusions: These studies reveal a surprising role for HIF1A in lung protection during ALI, where normoxic HIF1A
stabilization and HIF-dependent control of alveolar-epithelial glucose metabolism function as an endogenous feedback
loop to dampen lung inflammation.
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Introduction
Acute lung injury (ALI) is an inflammatory disease of the lungs
that is characterized by hypoxemic respiratory failure with
bilateral pulmonary infiltrates, not attributable to left heart failure
[1–4]. Among the hallmarks of ALI are severe arterial hypoxemia
and uncontrolled accumulation of inflammatory cells into different
compartments of the lungs, in conjunction with cytokine release
and inflammatory activation of recruited or resident cells.
Particularly alveolar epithelial injury plays a key role in the
pathogenesis of ALI, leading to disruptions of the alveolar-
capillary barrier function, resulting in extensive pulmonary edema,
attenuated gas exchange, and uncontrolled lung inflammation [2].
While there is currently no specific therapy available, management
consists of aggressive treatment of the initiating cause, vigilant
supportive care, and the prevention of nosocomial infections.
From a clinical perspective, it is important to point out that ALI is
among the leading causes of morbidity and mortality of patients
requiring critical care medicine. For example, a large scale
prospective, population-based, cohort study indicates that each
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which are associated with 74,500 deaths and 3.6 million hospital
days [5]. Moreover, long-term disabilities in ALI survivors are
significant. A landmark study who followed ALI survivors over 5
years revealed that exercise limitation, physical and psychological
sequelae, decreased physical quality of life, as well as increased
costs and use of health care services are important legacies of
severe lung injury [6]. Taken together, these studies highlight the
importance for finding novel ALI treatment approaches with the
goal to dampen excessive lung inflammation [2,7–9] or to support
its resolution phase [10–16].
While ALI has a major impact on the morbidity and mortality
of patients requiring critical care medicine and mechanically
ventilation, many episodes of ALI are self-limiting, and resolve
spontaneously through molecular pathways that are transcription-
ally controlled [10–12,17]. In spite of profound inflammatory
responses to surgery and mechanical ventilation [18], patients
undergoing major thoracic surgery for lung cancer have an overall
incidence of ALI of less than 5% [19], open heart surgery with
cardiopulmonary bypass less than 0.5% [20], or kidney transplan-
tation of less than 0.2% [21]. Based on these clinical observations,
we hypothesized that innate adaptive pathways exist that dampen
acute pulmonary edema and lung inflammation during ALI in
mechanically ventilated patients.
To identify novel endogenous pathways important for lung
protection and ALI resolution that are turned on by mechanical
ventilation, we utilized stretch exposure of pulmonary epithelial
cells as a single-cell-based in vitro model for ventilator-induced
ALI [22,23]. Very surprisingly, genome-wide microarray screen-
ing for alterations in gene transcription of human pulmonary
epithelial cells exposed to cyclic mechanical stretch conditions
revealed a transcriptional response that shared many similarities
with ambient hypoxia exposure. Subsequent studies identified a
molecular pathway resulting in normoxic stabilization of the
transcription factor hypoxia-inducible factor HIF1A during stretch
conditions in vitro or during ALI induced by mechanical
ventilation in vivo.
HIF is a transcription factor that is critical for tissue adaptation
to conditions of hypoxia [4,24–31]. More recently, HIF has also
been implicated in the control of immune responses during
inflammatory processes including ischemia and reperfusion,
cancer or mucosal inflammation [3,4,32–34]. Sites of acute
inflammation are frequently characterized by considerable shifts
in the supply and demand of metabolites that result in limited
oxygen availability (inflammation-associated hypoxia) [7,35–38].
Consistent with a role for hypoxia-signaling in cellular adaptation
to conditions of limited oxygen availability [31,36,39], several
studies implicate hypoxia-dependent signaling pathways in the
attenuation of mucosal inflammation [7,33,40–43]. Surprisingly
and in contrast to some of the above studies on inflammatory
hypoxia [36,37,44,45], we observed that pulmonary stabilization
of HIF1A during ALI occurs under normoxic conditions.
Consistent with previous studies [46–48], our findings implicate
a metabolic pathway in normoxic HIF stabilization, including
stretch-induced inhibition of succinate dehydrogenase (SDH)
activity. In fact, previous studies had indicated that normoxic
stabilization of HIF in cancer involves inhibition or mutation of
the metabolic enzyme SDH [46,48]. Extension of these initial
findings utilizing pharmacologic and genetic models of hypoxia-
signaling during ALI revealed that HIF controls a functional link
between alveolar epithelial metabolism and lung inflammation
during ALI, thus implicating pharmacologic strategies to activate
these HIF-dependent metabolic pathways for ALI treatment.
Indeed, compounds such as HIF activators have been used safely
in patients [49].
Results
Cyclic Mechanical Stretch of Alveolar Epithelia Is
Associated with a Transcriptional Program Resembling
Hypoxia-Signaling
Previous studies had demonstrated that ALI is associated with
significant alterations of gene-expression that frequently resembles
endogenous adaptive responses [2,7,35]. To systematically exam-
ine alterations of pulmonary gene expression during ALI, we
utilized a simple in vitro model of ALI by exposing human
pulmonary epithelia to cyclic mechanical stretch conditions. This
in vitro model resembles alveolar injury as occurs during
ventilator-induced ALI in humans [22,23,40]. For this purpose,
we examined human alveolar epithelial cells (Calu-3) following
24 h stretch exposure at 30% intensity by performing a genome
microarray screen (http://www.ncbi.nlm.nih.gov/projects/geo/
query/acc.cgi?acc=GSE27128). We subsequently confirmed the
array results utilizing real-time RT-PCR and Western blotting for
a subset of genes that were regulated (Table S1). Surprisingly,
computerized pathway analysis to examine alterations in gene
transcription (Ingenuity IPA, Version 11631407) revealed that
hypoxia-signaling resembled the dominant stress response path-
way when comparing stretch-exposed pulmonary epithelia to un-
stretched controls (Figure 1A; Figure S1). In fact, subsequent
studies of Calu-3 pulmonary epithelia exposed to different time-
periods of stretch (Figure 1B) or studies utilizing a HIF reporter
plasmid transfected into pulmonary epithelia (A549) and exposed
to stretch conditions revealed stabilization of HIF1A—the key
transcription factor for hypoxia adaptation (Figure 1C) [30].
Similarly, exposure to different degrees of cyclic mechanical
stretch (Figure 1D) showed stretch-dose-dependent stabilization of
HIF1A. Moreover, studies in primary human alveolar epithelial
cells demonstrated robust HIF1A stabilization following stretch
Author Summary
Acute lung injury is a devastating lung disease caused by
injuries or acute infections to the lung. In patients it
manifests itself as acute respiratory distress syndrome.
Severe pulmonary edema and uncontrolled lung inflam-
mation are typical symptoms of acute lung injury, which
make it hard for patients to breath efficiently. In the clinical
course of the disease, patients require mechanical venti-
lation to support their lung function and to provide
sufficient oxygen levels to vital organs such as the brain,
the heart, or the kidneys. We hypothesized that stretch
conditions—such as those that occur during mechanical
ventilation—result in transcriptional adaptation of alveolar
epithelial cells—the innermost lining of the lungs. In this
study we identified an unexpected involvement of the
transcription factor hypoxia-inducible factor HIF1A in lung
protection. We observed that during acute lung injury,
stabilization of HIF1A is mediated by increased levels of
succinate, an intermediate product of the citrate cycle.
Interestingly, we show that HIF1A in alveolar epithelia
functions to induce a transcriptional program that
improves the efficiency of carbohydrate metabolism by
injured lungs, thereby helping to adapt to the injurious
conditions of mechanical stretch and to reduce lung
inflammation. These preclinical findings highlight the
potential for pharmacological HIF1A stabilization in the
treatment of acute lung injury.
Alveolar Epithelial HIF1A Protects from ALI
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stretch has functional consequences, we generated pulmonary
epithelial cell lines with stable siRNA-mediated repression of
HIF1A (Figure S2A–C). As HIF1A functions as an important
regulator of glycolysis [50] we first explored the possibility of
stretch controlling transcription of glycolytic enzymes. Exposure of
control-transduced pulmonary epithelial cells demonstrated very
robust induction of the transcript levels for phosphofructokinase m
(PFKM), pyruvate dehydrogenase kinase 1 (PDK1) (Figure S3A),
and lactate dehydrogenase a (LDHA, Figure 1F) with stretch
exposure. In contrast, stretch-induced induction of glycolytic
enzymes was completely abolished in pulmonary epithelial cells
with HIF1A repression (Figure S3A and Figure 1F). Similarly,
stretch-induced increases of lactate levels in their supernatant or
increases in glycolytic flux as measured by metabolic turnover of
13C-labeled glucose during stretch were HIF1A-dependent
(Figure 1G, H). These findings were specific for HIF1A, as cells
with pulmonary epithelial cells with siRNA-mediated HIF2A
repression behaved similar to controls (Figures S2 and S3).
Together, these studies demonstrate stabilization of HIF1A during
cyclic mechanical stretch exposure of human pulmonary epithelial
cells in vitro and reveal transcriptional and functional conse-
quences of HIF1A stabilization on carbohydrate metabolism.
Stretch-Induced HIF1A Stabilization Occurs Under
Normoxic Conditions and Requires Stretch-Elicited
Inhibition of SDH
Based on the above findings that identified stabilization and
increased transcriptional and functional activity of HIF1A during
cyclic mechanical stretch conditions, we next pursued studies to
address the mechanism of stretch-induced HIF1A stabilization. As
a first option, we considered the possibility that stretch-associated
increases in oxygen consumption could lead to a decrease in
oxygen availability, and subsequent hypoxic stabilization of
HIF1A. Previous studies had shown that shifts in cellular oxygen
levels between the cytosol and the mitochondria—as caused by
nitric oxide—can cause HIF stabilization [51]. To address this
possibility, we performed measurements of oxygen partial
pressures within the supernatant of stretched pulmonary epithelial
cells (Figure 2A) [52]. However, we observed high oxygen partial
pressures in controls or stretched pulmonary epithelial cells,
indicating that HIF1A stabilization during stretch occurs under
normoxic conditions. Previous studies had indicated that normoxic
stabilization of HIF in cancer involves inhibition or mutation of
the metabolic enzyme SDH [46]. These studies demonstrate that
mutations of SDH are associated with inhibition of prolylhydrox-
ylases (PHDs)—a group of enzymes responsible for tagging HIF
for proteasomal degradation [24,53–55]—thereby causing nor-
moxic HIF stabilization [46–48]. To examine the possibility that
stretch-induced HIF1A stabilization could involve SDH inhibition,
we next examined the consequences of pulmonary epithelial
stretch exposure on SDH activity. We observed that stretch
exposure was associated with a very robust attenuation of SDH
activity (Figure 2B). To address if increased succinate levels with
following PHD inhibition were the mechanism for HIF1A
stabilization associated with low SDH activity, we generated cells
with siRNA repression of succinate-CoA ligase (SUCLG;
Figure 2C). While SDH inhibition leads to the accumulation of
succinate and succinate-elicited PHD inhibition, SUCLG deletion
would prevent the conversion of succinate-CoA to succinate and
thereby lower succinate levels [46–48]. As shown in Figure 2D,
stretch-induced HIF1A stabilization was completely abolished in
cells with siRNA-mediated SUCLG repression, thereby implicat-
ing a ‘‘succinate leak’’—caused by stretch-induced SDH inhibi-
tion—in normoxic HIF1A stabilization during cyclic mechanical
stretch of human pulmonary epithelial cells.
To further address the possibility of stretch-elicited inhibition of
SDH as a mechanism of normoxic HIF stabilization, we next
performed studies with cell permeable a-ketoglutarate in studies
on succinate-dependent HIF1A stabilization. Earlier studies found
that succinate-mediated inhibition of PHD is competitive and is
reversed by pharmacologically elevating intracellular a-ketogluta-
rate [56]. Introduction of a-ketoglutarate derivatives restores
normal PHD activity and HIF1A levels and thereby alleviates
pseudo-hypoxia. In fact and as shown in Figure 2E, a-ketogluta-
rate treatment prevented HIF1A stabilization in pulmonary
epithelia at 8 and 24 h of stretch.
To address possible mechanisms of stretch/stress-induced SDH
inhibition, we next pursued studies on the effect of stretch on stress
kinases. Recent studies found enhanced mitogen-activated protein
kinase (MAPK) activation following stretch of lung epithelia [57].
As such we measured SDH activity during stretch with and
without inhibitors of JNK, ERK, or p38. As shown in Figure 2F–
H, inhibition of these MAPKs abolished stretch-mediated SDH
inhibition. Based on reports of normoxic HIF1A stabilization by
pro-inflammatory cytokines [58], we next tested for stretch-
induced HIF1A expression under conditions of neutralization of
TNFA or IL-6 using neutralizing antibodies. As shown in
Figure 2I, TNFA or IL-6 neutralizing antibodies blunted stretch-
mediated HIF1A stabilization in lung epithelia. As TNFA is able
to up-regulate stress kinases such as p38 [59], these findings
indicate that TNFA release by stretched pulmonary epithelia
might be involved in the up-regulation of stress kinases with
concomitant inhibition of SDH activity.
Figure 1. Alterations of gene-expression following cyclic mechanical stretch exposure of pulmonary epithelial cells—An in vitro
model for ALI. Confluent Calu-3 or A549 cells were plated on collagen-coated BioFlex plates and underwent cyclic mechanical stretch for 24 h at
30% maximum, 0.7% stretch minimum, and sine wave 5 s on, 5 s off. (A) Pathway analysis. Microarray technology was used to assess transcriptional
changes in stretch versus control conditions. (B) Calu-3 pulmonary epithelia exposed to different time periods of 30% stretch. HIF1A protein levels
determined by Western blot. One representative blot of three is displayed. (C) HIF reporter plasmid consisting of four tandem HIF1A enhancer
sequences from the 39-region of the erythropoietin gene transfected into pulmonary epithelia (A549) and exposed to 30% stretch (n=3). (D) Calu-3
pulmonary epithelia exposed to different degrees of cyclic mechanical stretch. HIF1A protein levels determined by Western blot. One representative
blot of three is displayed. (E) Human alveolar epithelial cells (HPAEpiC) were exposed to different time-periods of stretch. Representative Western
blots are shown following 30% stretch. (F) Transcript level of the glycolytic enzyme LDHA from HIF1A KD Calu-3 pulmonary epithelia (lentivirus
mediated HIF1A knockdown, see Figure S2) or Calu-3 epithelia transduced with a control virus (lentiviral scrambled siRNA, Scr) after 24 h of stretch
were determined by real-time RT-PCR relative to housekeeping gene beta-actin (mean 6 s.d., n=3). (G) Lactate levels in supernatants obtained from
Calu-3 with a lentiviral-mediated HIF1A KD or controls (Scr) after 24 h of 30% stretch exposure. Controls consisted of Calu-3 cells treated with
lentiviral scrambled siRNA exposed to the same experimental conditions (n=4). (H) Calu-3 controls (Scr Calu-3; transfected with lentiviral scrambled
siRNA) or Calu-3 HIF1KD were exposed to 24 h of 30% stretch with media containing the
13C-glucose isotope. For nuclear magnetic resonance (NMR)
analysis of metabolites, cells were shock frozen immediately after stretch. Rate of glycolysis is given as ratio of incorporated
13C intermediates of
glycolysis compared to
13C glucose levels (n=4).
doi:10.1371/journal.pbio.1001665.g001
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associated alterations of metabolism beyond anaerobic glycolysis,
we next examined tricarboxylic acid cycle (TCA) flux and
mitochondrial functions of human pulmonary epithelial cells
(Calu-3) following siRNA-mediated HIF1A repression. As shown
in Figure 3A, studies tracing different cellular metabolites in the
presence of labeled glucose (
13C-glucose) revealed that TCA flux
was significantly increased in control cells, but not following
siRNA-mediated HIF1A repression. As HIF1A functions to
improve mitochondrial respiration and concomitant ATP produc-
tion during hypoxia, we next assessed if HIF1A-dependent TCA
flux increases during normoxia could be associated with increases
of HIF1A-dependent mitochondrial complex IV (COX4) activity
[60]. In fact, stretch exposure was associated with increased
COX4 activity and ATP levels in controls, but not in pulmonary
epithelial cells with HIF1A repression (Figure 3B,C). Together,
these findings indicate that HIF1A optimizes metabolic functions
during stretch conditions in vitro.
We next performed studies to better understand increases in
TCA substrate flux despite up-regulation of PDK1. As shown,
stretch stress causes normoxic HIF1A stabilization and HIF1A-
dependent glycolytic enzymes expression. Among them pyruvate
dehydrogenase kinase isoenzym 1 (PDK1) is up-regulated. This
enzyme is not to be confused with phosphoinositide-dependent-
kinase-1 (also abbreviated PDK1). The pyruvate dehydrogenase
kinase isoenzym 1 (PDK1) phosphorylates the enzyme of the same
name (specifically PDE1), which is the major component of the
pyruvate dehydrogenase complex (PDC). Phosphorylation of
pyruvate dehydrogenase at serine residue 1 of 3 possible ones by
PDK1 will almost completely inhibit activity of the PDC. As
shown in Figure 1G, inhibition of the PDC fits well with increased
production of lactate, as pyruvate is expected to accumulate
because it is less metabolized in the first step of the TCA controlled
by PDC activity. However, how does up-regulation of PDK1, a
master inhibitor of the PDC, fit to a several-fold increase in TCA/
C13-Gucose ratios (Figure 2E). To address this question, we next
measured mitochondrial PDC activity [61] during stretch condi-
tions. In particular, we measured the activity of the pyruvate
dehydrogenase (PDH). As shown in Figure 3D we found increases
of PDH activity in a HIF1A-dependent manner upon stretch.
These findings further supports our hypothesis of normoxic
HIF1A stabilization and HIF1A-dependent increases of TCA
cycle activity despite findings of PDK1 mRNA induction (Figure
S3). Consistent with a mitochondrial dysfunction in HIF1A knock-
down cells, we next observed increased reactive oxygen species
(H2O2, Figure 3E). Moreover, markers for epithelial cell inflam-
mation were elevated in Calu-3 cells with HIF1A repression
(Figure 3F–G). Similarly to the metabolic alterations, these
findings were specific for HIF1A, since HIF2A knockdown cells
showed similar responses as controls (Figure S3C). Together, these
findings indicate a functional role for normoxic HIF1A stabiliza-
tion during conditions of cyclic mechanical stretch in attenuating
pulmonary epithelial inflammation by optimizing cellular metab-
olism of carbohydrates.
Ventilator-Induced ALI Is Associated with Normoxic
HIF1A Stabilization in Vivo
After having observed a transcriptional hypoxia-program in
pulmonary epithelia exposed to stretch conditions in vitro, we
went on to examine HIF1A during in vivo conditions of ALI. For
this purpose, we utilized a previously described model of
mechanical ventilation-induced ALI [23,40,62]. We gained initial
insight from immune-histochemical studies of pulmonary tissues
following exposure to ALI. Consistent with in vitro studies of
stretch exposure, we observed increased HIF1A staining following
ALI induction (Figure 4A). Similarly, Western blotting indicated
that HIF1A stabilization during ALI is time-dependent and occurs
more pronounced with increased stretch conditions—such as those
encountered during mechanical ventilation at higher inspiratory
pressure levels (35 mbar versus 45 mbar; Figure 4B,C). In
addition, we examined pulmonary HIF1A levels utilizing a
previously characterized HIF reporter mouse model [63]. Consis-
tent with the above studies utilizing Western blotting for HIF1A,
we observed elevated HIF1A levels following ALI induction
(Figure 4D). Interestingly, studies utilizing different concentrations
of oxygen in the inspired air during ventilator-induced ALI (20%
oxygen versus 100% oxygen) demonstrated that HIF1A stabiliza-
tion is not affected by increasing the level of inspired oxygen
concentration—suggesting that HIF1A stabilization occurs under
conditions with sufficient oxygen availability (Figure 4E). Similarly
to stretch-associated HIF stabilization, we observed robust
repression of SDH activity following exposure to ALI induced
by mechanical ventilation (Figure 4F), thereby implicating SDH-
associated increases in succinate in the normoxic stabilization of
HIF during ALI. Together, these findings reveal normoxic
stabilization of HIF during ventilator-induced ALI.
Pharmacologic HIF1A Stabilization Attenuates Lung
Inflammation and Pulmonary Edema During ALI
Based on the above finding that HIF1A is stabilized during ALI,
we next performed pharmacologic studies to address the functional
role of HIF1A stabilization on ALI outcomes. First, we utilized the
HIF1A activator dimethyl-oxaloylglycine (DMOG). DMOG-
associated stabilization of HIF1A involves inhibition of PHDs
[64,65]—a mechanism very similar to succinate-dependent HIF
stabilization. For the purpose of these studies, we pretreated mice
with DMOG (1 mg i.p.) 4 h prior to the induction of ALI. This
pharmacologic approach was associated with robust HIF1A
Figure 2. Mechanisms of cyclic mechanical stretch-mediated HIF1A stabilization. (A) Confluent Calu-3 cells underwent cyclic mechanical
stretch for 24 h. Partial oxygen pressures (pO2) from supernatants were determined using I-STAT analyzer and compared to un-stretched controls
(mean 6 s.d., n=3). (B) Following 8 or 24 h of cyclic mechanical stretch exposure, mitochondrial fractions of Calu-3 cells were obtained and analyzed
for succinate dehydrogenase (SDH, mitochondrial Complex II) activity using ELISA. Activity is given as OD (optical density) change over time (mean 6
s.d., n=3). (C) siRNA knockdown of succinate-CoA ligase (SUCLG). RT PCR for SUCLG from A549 cells after siRNA treatment compared with control
siRNA treatment (CsiR; beta-actin was used as house-keeping gene; n=3). Note: siRNA knockdown revealed 82% reduction of SUCLG transcript. (D)
A549 cells following siRNA repression of succinate-CoA ligase (siSUCLG) or treatment with nonspecific control siRNA (CsiR) were stretched for 0 or 8 h,
lysed, and blotted for HIF1A. One representative blot of three is displayed. (E) Confluent Calu-3 cells underwent cyclic mechanical stretch for 8 or 24h
with and without a-ketoglutarate (aKG) treatment. Cells were lysed and blotted for HIF1A. One representative blot of three is displayed. (F–H)
Confluent Calu-3 cells underwent cyclic mechanical stretch for 8 h with or without inhibitors of JNK, ERK, or p38. Mitochondrial fractions of Calu-3
cells were obtained and analyzed for succinate dehydrogenase (SDH, mitochondrial Complex II) activity using ELISA. (I) Confluent Calu-3 cells
underwent cyclic mechanical stretch for 8 or 24 h with and without neutralizing antibodies for TNFA or IL-6. Cells were lysed and blotted for HIF1A.
One representative blot of three is displayed.
doi:10.1371/journal.pbio.1001665.g002
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revealed that ALI-associated increases in pulmonary edema were
dramatically improved following DMOG treatment (Figure 5A).
In addition, pre-treatment with DMOG was associated with
attenuated lung inflammation, as assessed by measurements of
myeloperoxidase levels in the lungs or in the BAL, indicating that
pretreatment with DMOG attenuates pulmonary neutrophil
accumulation in the lungs during ALI (Figure 5B,C). Similarly,
attenuated gas exchange during VILI was improved in mice pre-
treated with DMOG (Figure 5D). Finally, pre-treatment with
DMOG was also associated with a very dramatic increase of
survival time during VILI exposure (Figure 5E). Together, these
pharmacologic studies indicate that stabilization of HIF during
ALI functions to dampen pulmonary edema and lung inflamma-
tion during ALI induced by mechanical ventilation in vivo.
Inhibition of HIF1A Functions Is Detrimental During ALI
After having observed very robust therapeutic effects for the
treatment with a pharmacologic HIF activator, we next examined
the consequences of a pharmacologic inhibitor of HIF1A activity.
For these studies we utilized echinomycin, which prevents binding
of HIF1A to the DNA, thereby preventing functional HIF1A
activation [66]. Echinomycin pretreatment prevented HIF-depen-
dent induction of pulmonary HIF target genes, such as PFKM,
PDK1, or LDHA transcript levels (Figure S4B). In contrast to
studies with the HIF1A activator DMOG, we observed increased
pulmonary edema (Figure 6A), in conjunction with increased
pulmonary and BAL myeloperoxidase levels (Figure 6B,C),
attenuated gas exchange (Figure 6D), and decreased survival time
during ventilator-induced ALI in mice that were pre-treated with
the HIF inhibitor echinomycin (Figure 6E). Together, these
pharmacologic studies indicate that inhibition of the transcrip-
tional functions of HIF during ALI is highly detrimental,
implicating normoxic HIF1A stabilization in an endogenous
feedback loop to protect the lungs from excessive inflammation
and pulmonary edema during ALI.
Alveolar-Epithelial HIF Signaling Mediates Lung
Protection During ALI
To gain insight into the tissue-specific source of HIF1A-
dependent lung protection, we next performed genetic studies for
HIF1A during ventilator-induced ALI. Due to the fact that
Hif1a
2/2 mice die during embryogenesis [67–69], we utilized
transgenic mice with a ‘‘floxed’’ HIF1A gene [70] to systematically
delete HIF1A in different tissue compartments of the lungs. As first
step, we generated mice with induced deletion of HIF1A in all
tissues, including the lungs (Hif1a
f/fActinCre+, Figure S4C).
Consistent with our above findings with pharmacologic HIF
inhibition, we observed dramatic decreases in survival time, paired
with increased pulmonary edema and attenuated gas exchange
during ALI exposure of Hif1a
f/f ActinCre+ mice compared to
ActinCre+ controls (Figure 7A). In contrast, mice with deletion of
HIF1A in vascular endothelia (Hif1a
f/f CadherinCre+; Figure 7B,
Figure S5A), myeloid cells (Hif1a
f/f LysozymCre+; Figure 7C) [70],
or the conducting airways (Hif1a
f/f ClaraCellCre+; Figure 7D,
Figure S5B) [71] showed no difference in survival time, pulmonary
edema, or gas-exchange during ALI as compared to correspond-
ing controls. However, mice with induced deletion of HIF1A in
their alveolar epithelial cells (Hif1a
f/f SurfactantCre+; Figure 7E,
Figures S5C and S6) [72] showed a similar phenotype as mice with
induced deletion of HIF in all tissues. Indeed, Hif1a
f/f Surfac-
tantCre+ demonstrated attenuated survival time, increased pul-
monary edema, and attenuated gas exchange during ventilator-
induced ALI. Taken together, these studies provide genetic in vivo
evidence for a protective role for alveolar-epithelial-specific
HIF1A-signaling during ALI.
Hif1a
f/f SurfactantCre+ Mice Experience Profound Lung
Inflammation During ALI
Based on the above studies implicating alveolar epithelial
HIF1A in lung protection during ALI, we performed a more
detailed examination of mice with conditional deletion of HIF1A
in pulmonary epithelia (Hif1a
f/f SurfactantCre+). Isolation of
alveolar epithelial cells from Hif1a
f/f SurfactantCre+ or control
mice after exposure to mechanical ventilation confirmed alveolar-
epithelial HIF1A stabilization in controls but not in Hif1a
f/f
SurfactantCre+ (Figure 8A, Figure S6). Additional functional
studies of Hif1a
f/f SurfactantCre+ demonstrated a more profound
degree of lung inflammation during ALI, including increased
pulmonary neutrophil accumulation (Figure 8B), pulmonary IL-6
(Figure 8C), CXCL1 (Figure 8D), and pulmonary TNF-a levels
(Figure 8E). Similarly, pulmonary injury as assessed by a VILI
score (Figure 8F) and as shown in a representative histologic slides
(Figure 8G) was dramatically increased in Hif1a
f/f SurfactantCre+
upon exposure to ALI induced by mechanical ventilation. In
addition, the lung protective effects of pharmacologic treatment
with the HIF activator DMOG on albumin leakage (Figure 8H),
pulmonary gas exchange (Figure 8I), and neutrophil accumulation
in the lungs (Figure 8J) were abolished in mice with conditional
HIF1A deletion in the alveolar epithelia, indicating that DMOG-
elicited lung protection requires the presence of pulmonary
epithelial HIF1A, as opposed to alternative tissue-specific sources
for HIF1A such as endothelia or myeloid cells. Taken together,
these findings implicate alveolar-epithelial HIF1A in dampening
lung inflammation during ALI.
Alveolar-Epithelial HIF1A Dampens Lung Inflammation
by Enhancing Glycolysis and Optimizing Mitochondrial
Respiration During ALI
Based on the above in vitro studies on the role of HIF1A in
optimizing pulmonary epithelial carbohydrate metabolism during
conditions of cyclic mechanical stretch, we next examined
Figure 3. Functional consequences of cyclic mechanical stretch mediated HIF1A stabilization. (A) Calu-3 controls (Scr Calu-3; treated with
lentiviral scrambled siRNA) or Calu-3 HIF1KD were exposed to 24 h of stretch with media containing the
13C-glucose isotope. For nuclear magnetic
resonance (NMR) analysis of metabolites, cells were shock frozen immediately after stretch. Rate of tricarboxylic acid cycle (TCA) flux is given as ratio
of incorporated
13C intermediates of the TCA compared to
13C glucose levels. (B) After 24 h of cyclic mechanical stretch, mitochondrial fractions of
Calu-3 cells were obtained and analyzed for mitochondrial Complex IV (COX4) activity using ELISA. Activity is given as OD (optical density) change
over time (mean 6 s.d., n=3). (C) ATP levels from Calu-3 controls (Scr Calu-3) or Calu-3 HIF1KD exposed to 24 of stretch. (D) Pyruvate dehydrogenase
(PDH) activity levels from Calu-3 controls (Scr Calu-3) or Calu-3 HIF1KD exposed to 8 or 24 h of stretch. (E) Hydrogen peroxide levels of supernatants
from Calu-3 controls or Calu-3 cells after 24 h at 30% stretch and 20% O2. The H2O2 data are expressed as the mean fluorescence levels from two
independent experiments normalized by protein concentration. Error bars represents s.d. (n=3). (F–G) IL-6 and TNF-a levels were evaluated in
supernatants from stretched Calu-3 controls or Calu-3 HIF1KD exposed to 24 h of stretch using a human enzyme linked immunosorbent assay
(ELISA). Results are presented as mean 6 s.d. (n=3).
doi:10.1371/journal.pbio.1001665.g003
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vivo. For this purpose—and as we have done in previous studies
[73]—we employed liquid chromatography–tandem mass spec-
trometry analysis of
13C-glucose metabolites. In line with the
hypothesis that alveolar-epithelial HIF1A optimizes carbohydrate
metabolism during ALI in vivo, we found that elevations of
pulmonary glucose levels during ALI were completely abolished in
Hif1a
f/f SurfactantCre+ (Figure 9A). Similarly, transcript levels of
the glucose transporter Glut1 were dramatically increased
following ALI in control mice but not in Hif1a
f/f SurfactantCre+
(Figure 9B). Moreover, we observed that ALI-associated elevations
of [
13C6]-fructose 1,6 bisphosphate and [
13C6]-lactate following
exposure to ALI were completely abolished in Hif1a
f/f Surfac-
tantCre+ (Figure 9C,D). Similarly, ALI-associated elevations of the
transcript levels of glycolytic enzymes were attenuated in Hif1a
f/f
SurfactantCre+ mice (Figure S7A). Taken together, these data
indicate that ALI induced by mechanical ventilation is associated
with a transcriptional program under the control of alveolar-
epithelial HIF1A that leads to an increase in glycolytic flux. To
address the functional role of HIF-dependent induction of the
glycolytic pathway, we next performed in vivo studies with the
glycolysis inhibitor 2-deoxy-D-glucose (2-DG), a well-character-
ized inhibitor of glycolysis [74]. Here we found that treatment with
2-DG (200 mg/kg i.p. prior to the induction of ventilator-induced
ALI) was associated with increased pulmonary edema (Figure 9E),
attenuated gas exchange (Figure 9F), enhanced pulmonary
neutrophil accumulation as assessed by MPO levels (Figure 9G),
and cytokine production (IL-6; Figure 9H). Moreover, survival
time during ALI exposure of anesthetized mice was significantly
reduced following pretreatment with 2-DG as compared to vehicle
treatment in wild-type mice (Figure 9I), while 2-DG treatment of
Hif1a
f/f SurfactantCre+ mice had no effect on survival time
(Figure 9J). Similar, while 2-DG treatment increased H2O2
production in wild-type mice—indicating mitochondrial stress—
2-DG treatment did not further increase H2O2 levels in Hif1a
f/f
SurfactantCre+ mice (Figure S7B). Taken together, these studies
indicate that enhancing the glycolytic carbohydrate flux during
ALI is mediated exclusively through alveolar epithelial HIF1A.
Moreover, pharmacologic studies using an inhibitor for glycolysis
implicate transcriptional increases in lung epithelial glucose
metabolism as an endogenous adaptive pathway to dampen
inflammation during ALI in vivo.
Alveolar Epithelial HIF1A Increases TCA Flux and
Mitochondrial Activity During ALI in Vivo
To gain additional insight into the metabolic functions of
epithelial HIF1A during ALI in vivo, we next pursued metabolic
studies on TCA flux and mitochondrial metabolism in Hif1a
f/f
SurfactantCre+ mice. Consistent with the above studies in
stretched pulmonary epithelial cells in vitro, we observed that
ALI-associated increases in [
13C]-malate and TCA flux rates were
completely abolished in mice with gene-targeted deletion of
HIF1A in alveolar epithelia (Figure 10A,B), suggesting that
alveolar epithelial HIF1A specifically promotes TCA flux during
ALI in vivo. Based on our in vitro studies implicating HIF1A in
stretch-induction of mitochondrial complex IV (COX4), and
previous studies showing that HIF1A regulates cytochrome
oxidase subunits to optimize efficiency of respiration in hypoxic
cells [60], we next performed an analysis of COX4 activity along
with the protein expression of the cytochrome oxidase subunit
COX4-2 during ALI. Here, we found a very robust increase of
COX4 activity and the induction of COX4-2 protein levels in
control mice exposed to ALI (Figure 10C,D). In contrast, in vivo
studies using Hif1a
f/f SurfactantCre+ mice during ALI demon-
strated that the observed induction was completely abolished in
mice with alveolar epithelial deletion of HIF1A. Accordingly,
increases in pulmonary ATP levels following ALI were abolished
in Hif1a
f/f SurfactantCre+ mice (Figure 10E). Consistent with a
mitochondrial dysfunction in Hif1a
f/f SurfactantCre+ mice during
ALI, we found higher ROS levels (Figure 10F). Similarly, complete
inhibition of mitochondrial respiration utilizing rotenone treat-
ment in wild-type animals exposed to ventilator associated lung
injury was associated with dramatically increased lung inflamma-
tion (IL-6 levels displayed; Figure 10G) or alveolar lung leakage
(BAL albumin; Figure 10H), thereby mimicking our previous
findings in Hif1a
f/f SurfactantCre+ mice. Taken together, these
studies indicate that HIF-dependent optimization of glucose
uptake, glycolysis, TCA flux, and respiration of the alveolar
epithelium represents an endogenous adaptive process that
counter-regulates pathologic lung inflammation and improves
survival during ventilator-induced ALI (Figure 11A).
Discussion
The present study was designed to identify stress-elicited
transcriptional pathways that could be targeted as novel treatment
for ALI. For this purpose, we performed a genome-wide screen to
identify transcriptional responses to cyclic mechanical stretch of
pulmonary epithelial cells, such as occurs during mechanical
ventilation in the context of ALI. Quite surprising, these studies
revealed a transcriptional response that resembled hypoxia
signaling. We found that the key transcription factor for mediating
hypoxia adaptation—HIF1A—was stabilized during stretch con-
ditions in vitro, or during ALI induced by mechanical ventilation
in vivo. Unexpectedly, HIF1A stabilization occurred in the
absence of tissue hypoxia, and involved normoxic inhibition of
SDH, a molecular pathway that has previously been implicated in
the normoxic activation of HIF during cancer [46–48]. In order to
define the functional role of HIF1A during ALI, we subsequently
Figure 4. Normoxic HIF1A stabilization during ALI. (A) Wild-type mice (BL6C57) were exposed to ventilator induced lung injury (VILI; pressure-
controlled mechanical ventilation at an inspiratory pressure of 45 mbar with an inspired oxygen concentration of 100%, exposure time 180 minutes).
To examine the influence of mechanical ventilation on pulmonary HIF1A expression patterns, lungs were stained with antibodies for Hif1a. IgG
controls were used at identical concentrations and staining conditions as the target primary antibodies (magnification 6400; n=4). (B) Frozen lung
tissue was lysed and proteins resolved by SDS-PAGE. Resultant Western blots were probed with anti-Hif1a antibody. A representative blot of three is
displayed. (C) Quantitative analysis of Western blot in (B) assessed by densitometry. (D) Imaging HIF1A using previously described HIF reporter mice
expressing luciferase upon HIF stabilization (‘‘ODD-Luc mice’’) during ALI. Prior to imaging, mice were injected with i.p. luciferin (50 mg/kg) and mice
were euthanized. Left column (control): Lungs excised without mechanical ventilation. To induce ALI, mice were ventilated with pressure controlled
ventilation (45 mbar) at 21% oxygen concentration over 3 h. Middle column, 3 h at 15 mbar; right column, 3 h at 35 mbar. Color bar indicates
photons/(cm2?s?steradian) with minimum and maximum threshold values (n=4). (E) ‘‘ODD-Luc mice’’ were exposed to VILI (45 mbar, 3 h) using 20%
or 100% inspired oxygen. Lungs were harvested, homogenized, and analyzed for luciferase gene expression using the Dual-Luciferase Reporter Assay
System from Promega. (F) After 3 h of ventilation at 45 mbar, mitochondrial fractions obtained from lung tissue were analyzed for succinate
dehydrogenase (SDH, mitochondrial Complex II) activity using ELISA. Activity is given as OD (optical density) change over time (mean 6 s.d., n=3).
doi:10.1371/journal.pbio.1001665.g004
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tors. These findings demonstrated a protective role for HIF
stabilization during ALI. Systematic deletion of the Hif1a gene in
different lung tissues identified a predominant role for alveolar
epithelial HIF1A signaling in these responses. Subsequent
metabolic studies indicated that stretch exposure of pulmonary
epithelial cells in vitro or ventilator-induced ALI in vivo is
associated with the normoxic stabilization of HIF1A, thereby
leading to increased glycolytic capacity, TCA flux, optimized
mitochondrial respiration, and finally increased ATP generation.
Indeed, HIF-dependent prevention of mitochondrial dysfunction
during ALI resulted in increased alveolar epithelial capacity to
produce ATP, while concomitantly preventing ROS accumulation
and lung inflammation (Figure 11).
We were surprised to find a functional role for pulmonary
hypoxia-signaling during ALI—particularly because the lungs
represent one of the best oxygenated environments in the body.
However, this is not the first time that studies uncovered a
surprising manifestation for hypoxia-signaling under normoxic
conditions. As such, lactate and pyruvate have been shown to
regulate hypoxia-inducible gene expression independently of
hypoxia by stimulating the accumulation of HIF1A in human
gliomas and other cancer cell lines [75]. In contrast to those
studies, we observed that HIF stabilization occurred during ALI
under normoxic conditions. Combinations of in vitro stretch
studies of pulmonary epithelial cells and in vivo studies of ALI
induced by mechanical ventilation implicate stretch-elicited
inhibition of SDH in HIF activation. These findings are consistent
with previous studies of SDH-dependent HIF activation [46–48].
Studies on mutations in human cancers had implicated SDH in
altered cellular metabolism and cellular transformation. Inactivat-
ing SDH causes the accumulation of succinate, which inhibits 2-
oxoglutarate-dependent enzymes, including PHDs that mark
HIF1A for polyubiquitylation and proteasomal degradation [48].
In support of these findings, other studies have redundantly shown
the critical role of metabolism in regulating HIF1A-dependent
gene expression [76].
Also consistent with the current studies, previous studies have
shown molecular pathways for normoxic stabilization of HIF1A.
For example, a recent study described hypoxia-independent
activation of HIF1A by enterobacteriaceae and their siderophores
[77]. Several studies had provided evidence for HIF1A stabiliza-
tion during bacterial infections [78–80]. In extension of these
findings, the authors pursued the role of bacterial siderophores in
HIF1A activation during infection with Enterobacteriaceae.
Infection of mice with Y. enterocolitica led to functional activation
of HIF1A in Peyer’s patches. Because mice with deletion of HIF1A
in the intestinal epithelium showed a significantly higher
susceptibility to orogastric Y. enterocolitica infections, activation of
HIF1A in host cells during bacterial infection represents a host
defense mechanism in this study. Additional studies with Y.
enterocolitica, S. enterica subsp enterica,o rE. aerogenes, and moreover,
application of their siderophores (yersiniabactin, salmochelin,
aerobactin), caused a robust, dose-dependent HIF1A response in
human epithelia and endothelia, independent of cellular hypoxia
[77]. The authors conclude that bacterial siderophores account for
the normoxic stabilization of HIF1A during infection with human
pathogenic bacteria.
In the context of lung injury, previous studies had shown an
indirect role for hypoxia-signaling in attenuating ALI induced by
bacterial infection [81]. For example, an important study tested
the hypothesis that oxygenation weakens a tissue-protecting
mechanism triggered by hypoxia and concomitant HIF activation
[41]. The authors found that the hypoxia-dependent transcrip-
tional control of extracellular adenosine signaling protects the
lungs from the toxic effects of overactive immune cells such as
neutrophils [35]. In line with the present studies, these findings
demonstrate a protective role for the activation of the HIF-
pathway in the lungs by attenuating pathologic lung inflammation
during ALI. These studies pointed towards a protective role for
HIF-elicited increases of adenosine signaling through the Adora2a
adenosine receptor [7,8]. During conditions of ischemia or
inflammation, different cells release nucleotides that can be
enzymatically converted to adenosine [2,23,38,82–85]. HIF1A
can function in multiple ways to enhance the protective effects of
extracellular adenosine signaling during ALI, including enhanced
enzymatic adenosine production by transcriptionally inducing the
ecto-59-nucleotidase (conversion of extracellular AMP to adeno-
sine), which is a known HIF target gene [86,87]. Similarly, other
studies had shown a protective role for the extracellular
production of adenosine and signaling events through adenosine
receptors in lung protection—for example, by attenuating vascular
leakage [88–91] or improving alveolar fluid transport [40].
Moreover, other studies also implicate HIF in attenuating
adenosine uptake via repression of equilibrative nucleoside
transporters, and thereby enhancing extracellular-dependent tissue
protection via adenosine signaling events [92–95]. Interestingly,
CD73 was among the genes regulated during stretch exposure of
pulmonary epithelial cells in our present study (Table S1).
Consistent with a role of HIF-dependent increases of CD73-
dependent adenosine generation and lung protection during ALI,
we also found that the protective effects of the HIF activator
DMOG was attenuated in gene-targeted mice for cd73 (Figure S8).
Taken together, these studies indicate the likelihood that HIF-
dependent lung protection during ALI may also involve HIF-
elicited increases in extracellular adenosine receptor signaling
[96,97]. However, it remains presently unclear if the findings of
HIF1A-elicited improvements in carbohydrate metabolism of
pulmonary epithelial cells are related or independent of adenosine
metabolism and signaling. Moreover, it will be important to
examine the role of this pathway in additional models of lung
injury, such as ischemia reperfusion and second organ reflow
injury of the lung [98] or in models of inflammatory lung disease
[99,100].
Other previous studies had implicated a functional role of HIF-
dependent induction of glycolysis in inflammatory diseases. For
Figure 5. Functional consequences of HIF1A activation during ALI. (A–E) HIF1A activator dimethyl-oxaloylglycine (DMOG) during ALI: BL6C57
mice were treated with 1 mg DMOG or vehicle control 4 h prior to the experimental procedure. (A) Mechanical ventilation was instituted and mice
were ventilated for 0 or 180 min using pressure-controlled settings (inspiratory pressure of 45 mbar, 100% inspired oxygen concentration). Albumin
concentration in the bronchoalveolar fluid (BAL) was determined by enzyme linked immunosorbent assay (n=6). (B and C) Pulmonary neutrophil
sequestration was quantified using a myeloperoxidase (MPO) assay. MPO activity was assessed using a murine ELISA from lung tissue (B) or BAL (C)
(mean 6 s.d., n=6). (D) To assess pulmonary gas exchange, blood gas analyses were performed by obtaining arterial blood via cardiac puncture.
Analysis was performed immediately and the ratio of the arterial partial pressure of oxygen (PaO2) to the fraction of inspired oxygen (FiO2) was
determined (mean 6 s.d., n=6). (E) Mechanical ventilation was instituted and mice were ventilated using pressure-controlled settings (inspiratory
pressure of 35 mbar, 100% inspired oxygen concentration) until a cardiac standstill was observed in the surface electrocardiogram (n=6).
doi:10.1371/journal.pbio.1001665.g005
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required for myeloid cell metabolism, and for their capability to
function during conditions of inflammatory hypoxia [70]. These
studies demonstrated that stabilization of HIF1A is essential for
myeloid cell infiltration and activation in vivo via functioning as
a essential regulator for their glycolytic capacity: when HIF1A is
absent, the metabolic defect results in profound impairment of
myeloid cell aggregation, motility, invasiveness, and bacterial
killing [70]. However, during conditions of ALI—such as those
that were used in the present studies—the lungs remain
normoxic, and PMN-dependent HIF stabilization and HIF-
elicited increases of PMN-inflammatory functions appear to be
an unlikely scenario. In contrast, stretch-induced stabilization of
HIF1A under normoxic conditions in epithelial cells appears to
contribute to lung protection during ALI. Indeed, HIF-
dependent increases in alveolar epithelial cell glycolysis, TCA
cycle flux, and mitochondrial respiration allows for a metabolic
adaptation that is critical to dampen pathologic lung inflam-
mation during ventilator-induced lung injury.
Consistent with the present studies implicating HIF in
mitochondrial respiration during ALI, a previous study had
demonstrated a functional role of HIF1A in mitochondrial
respiration via altering mitochondrial complex IV (COX4) subunit
composition under hypoxic conditions [60]. Moreover, the current
metabolic in vivo studies in mice with tissue-specific deletion of
HIF1A in alveolar epithelia are consistent with previous studies
from the 1970s that examined normoxic or hypoxic metabolism of
cultured pulmonary epithelia. During air cultivation, alveolar
epithelial cells had a high rate of aerobic and anaerobic glycolysis
[101]. However, the authors observed concomitant increases of
anaerobic and aerobic glycolysis under hypoxic condition [101].
These findings are consistent with the present studies showing that
HIF1A is responsible for increases of glycolysis and lactate
production and, at the same time, for oxidative glucose flux rates
during ALI in vivo. Our findings utilizing liquid chromatography–
tandem mass spectrometry analysis of metabolites following the
infusion of
13C-glucose-labeled glucose in mice with tissue-specific
deletion of alveolar epithelial HIF1A link these early observations
with a functional role for HIF1A in controlling alveolar epithelial
metabolism during ALI.
Taken together, the present studies demonstrate a critical role
for the stabilization of HIF1A during conditions of cyclic
mechanical stretch in vitro, or during ALI in vivo, representing
an endogenous protective mechanism. We conclude that targeting
HIF-dependent metabolism of alveolar epithelia during ALI
represents a powerful therapeutic strategy to dampen lung
inflammation. These findings are also interesting from a transla-
tional perspective: a pharmacologic activator of HIF has recently
been studied in the treatment of patients with renal anemia, and
there were no safety concerns observed [49]. As such, treatment of
ALI with HIF activators could potentially be considered in a
clinical trial of ALI. Based on the specificity of our findings for
pulmonary epithelial HIF1A, an inhaled treatment approach with
less systemic concentrations of the compound may also be feasible.
Materials and Methods
Ethics Statement
Experimental protocols were approved by the Institutional
Review Board at the University of Colorado Anschutz Medical
Campus, Aurora, Colorado. They were in accordance with the
U.S. Law on the Protection of Animals and the National Institutes
of Health guidelines for use of live animals.
Cell Culture and Treatments
Calu-3 human airway epithelial cells or human pulmonary
epithelial A549 cells were cultured as described previously [23,40].
Primary pulmonary epithelial cells (HPAEpiC) (ScienCell Re-
search Laboratories, California) were cultured according to the
supplier’s instructions.
In Vitro Stretch Model
To study the consequences of cyclic mechanical stretch, we
adopted a previously described in vitro model resembling
mechanical ventilation by applying cyclic mechanical stretch. In
short, Calu-3, A549, or HPAEpiC were plated on BioFlex culture
plates-collagen type I (BF-3001C; FlexCell International) and
allowed to attach and grow to 80% confluence. All cells were
cultured in 4 ml media: Calu-3 cells were grown in Advanced
MEM (GIBCO), A549 cells were grown in DMEM-F12 (GIBCO),
both cell lines with 10% FBS, 0.02% L-Glutamine. Plates were
then placed on a FlexCell FX-4000T Tension Plus System and
stretched at percentage stretch indicated, 30% maximum, 0.7%
stretch minimum, and sine wave 5 s on, 5 s off. Cells were
collected at indicated time points from duplicate wells, flash-
frozen, and stored at 280uC for further analysis. For control, cells
were cultured under similar conditions at rest (no cyclic
mechanical stretch).
Microarray Analysis
Array data have been deposited at GEO (accession number
GSE 27128) (http://www.ncbi.nlm.nih.gov/projects/geo/query/
acc.cgi?acc=GSE27128). The transcriptional profile in Calu-3
cells subjected to 30% stretch for 24 h was assessed from total
RNA (isolated using Qiagen RNeasy kit) using quantitative
GeneChip arrays (Human genome U133 Plus 2.0 Array). The
integrity of RNA was assessed using an Agilent 2100 Bioanalyzer
(Agilent Technologies), and RNA concentration was determined
using a NanoDrop ND-1000 spectrophotometer (NanoDrop,
Rockland, Delaware). Biotinylated cRNAs for hybridization to
Affymetrix 39-arrays were prepared from total RNA using the
Affymetrix two-cycle target labeling assay with spike in controls
(Affymetrix Inc., Santa Clara, California). Labeled-cRNA was
fragmented and hybridized to Human Genome Arrays following
Figure 6. Functional consequences of HIF1A inhibition during ALI. (A–E) HIF1A inhibition by Echinomycin during VILI: BL6C57 mice were
treated with 30 mg Echinomycin i.p. or vehicle control 1 h prior to the experimental procedure. (A) Mechanical ventilation was instituted and mice
were ventilated for 0 or 180 min using pressure-controlled settings (pressure-controlled mechanical ventilation at an inspiratory pressure of 45 mbar
with an inspired oxygen concentration of 100%, exposure time 180 min). Albumin concentration in the bronchoalveolar fluid (BAL) was determined
by enzyme linked immunosorbent assay (n=6). (B and C) Pulmonary neutrophil sequestration was quantified using a myeloperoxidase (MPO) assay.
MPO activity was assessed using a murine ELISA from lung tissue (B) or BAL (C) (n=6). Results are presented as mean 6 s.d. and derived from six
animals in each condition. (D) To assess pulmonary gas exchange, blood gas analyses were performed by obtaining arterial blood via cardiac
puncture. Analysis was performed immediately and the ratio of the arterial partial pressure of oxygen (PaO2) to the fraction of inspired oxygen (FiO2)
was determined (mean 6 s.d., n=6). (E) Mechanical ventilation was instituted and mice were ventilated using pressure-controlled settings
(inspiratory pressure of 35 mbar, 100% inspired oxygen concentration) until a cardiac standstill was observed in the surface electrocardiogram (n=6).
doi:10.1371/journal.pbio.1001665.g006
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arrays were scanned using a GCS3000 with the latest 7G upgrade.
Each array was subjected to visual inspection for gross abnormal-
ities. Several other QC metrics were used to monitor hybridization
efficiency and RNA integrity over the entire processing procedure.
Raw image files were processed using Affymetrix GCOS 1.3
software to calculate individual probe cell intensity data and
generate CEL data files. Using GCOS and the MAS 5.0
algorithm, intensity data were normalized per chip to a target
intensity TGT value of 500 and expression data and present/
absent calls for individual probe sets calculated. Quality control
was performed by examining raw DAT image files for anomalies,
confirming each GeneChip array had a background value of less
than 100, monitoring that the percentage present calls was
appropriate for the cell type, and inspecting the poly(A) spike in
controls, housekeeping genes, and hybridization controls to
confirm labeling and hybridization consistency. According to our
experimental setup, the arrays were normalized, grouped, and
analyzed for differentially expressed transcripts based on different
statistical tests. Different clustering algorithms allowed us to
identify transcripts that show similar expression profiles. Using the
‘‘Ingenuity Pathway Analysis,’’ we were able to identify biological
mechanisms, pathways, and functions most relevant to our
experimental dataset (Table S1, Figure S1).
Immunoblotting and Immunohistochemistry
Experiments
All antibodies used were anti-HIF1A mouse monoclonal
[H1alpha67] (Abcam), anti-HIF1A mouse monoclonal [H1al-
pha67] (Novus), anti-HIF2A rabbit polyclonal (Novus), and anti-
COX 4|2 mouse monoclonal (R&D). COX4|2 immunoblotting
was performed using mitochondrial protein fractions.
Lentiviral-Mediated Generation of Cells with Knockdown
of HIF1A and HIF2A
Stable cell cultures with decreased HIF1A and HIF2A
expression were generated by lentiviral-mediated shRNA expres-
sion. pLKO.1 lentiviral vectors targeting HIF1A had shRNA
sequence of CCG GCC AGT TAT GAT TGT GAA GTT ACT
CGA GTA ACT TCA CAA TCA TAA CTG GTT TTT (TRCN
0000003809), and HIF2A had a sequence CCG GCC ATG AGG
AGA TTC GTG AGA ACT CGA GTT CTC ACG AAT CTC
CTC ATG GTT TTT (TRCN 0000003807). For controls,
nontargeting control shRNA (SHC002;Sigma) was used.
HEK293T cells were co-transfected with pLK0.1 vectors and
packaging plasmids to produce lentivirus. Filtered supernatants
were used for infection of Calu-3 and cells were selected with
puromycin (30 ug ml
21) for at least two passages before initiating
stretch experiments.
Transcriptional Analysis
Total RNA was isolated from human lung epithelia or murine
lung tissue and transcript levels were determined by real-time
RT-PCR (iCycler; Bio-Rad Laboratories Inc.) [90]. Primers were
Quantitect from Qiagen.
Lactate Measurements and Blood Gas Analysis
To assess partial oxygen pressures (pO2) and lactate from cell
supernatants or to determine pulmonary gas exchange (paO2)i n
mice from arterial blood obtained via cardiac puncture, samples
were analyzed immediately after collection with the I-STAT
Analyzer (Abbott).
NMR Analysis on Stretched Calu-3 Cells
All 1H-NMR spectra were obtained at the Bruker 500 MHz
DRX NMR spectrometer using an inverse Bruker 5-mm TXI
probe. High-resolution
1H- and
13C-NMR experiments were
performed with the Bruker 500 MHz DRX spectrometer
equipped with an inverse 5-mm TXI probe (Bruker BioSpin,
Fremont, California) and
31P-NMR experiments with the
300 MHz Bruker Avance system with a 5-mm QNP probe. For
proton NMR, a standard water presaturation pulse program was
used for water suppression; spectra were obtained at 12 ppm
spectral width, 32K data arrays, 64 scans with 90-degree pulses
applied every 12.8 s. Trimethylsilyl propionic-2,2,3,3,-d4 acid
(TSP, 0.5 mmol/L) was used as an external standard for
metabolite chemical shift assignment (0 ppm) and quantification.
13C-NMR spectra with proton decoupling were recorded using the
C3-lactate peak at 21 ppm as chemical shift reference (spectral
width was 150 ppm, 16K data arrays, 20K scans applied every
3 s). [3-
13C] lactate satellite peak (at 1.23 ppm) from 1H-NMR
spectra served as an internal standard for
13C-NMR spectra (at
21 ppm) for calculation of
13C-enrichment of glucose and glucose
metabolites.
31P-NMR spectra were obtained using the spectral
width of 50 ppm and 16K data arrays, with 6K–10K scans being
applied every 3.5 s. Before
31P-NMR spectra were recorded,
EDTA (100 mmol/L) was added to each PCA extract to complex
divalent cations. Methylene diphosphonic acid (2 mmol/L) was
used as an external standard for chemical shift references
(18.6 ppm) and for metabolite quantification in
31P-NMR. For
nuclear magnetic resonance (NMR) analysis of metabolites, cells
were shock frozen immediately after stretch. Rate of glycolysis or
TCA cycle flux is given as ratio of incorporated
13C intermediates
of glycolysis compared to
13C glucose levels. All data were
processed using the Bruker WINNMR program. All NMR
experiments were performed at the Metabolomics NMR Univer-
sity of Colorado Cancer Center Core.
Mitochondrial Complex II and IV and PDH Activity
Measurement
Succinate Dehydrogenase (SDH, Complex II Enzyme Activity
Microplate Assay Kit, Abcam) or COX4 (Complex IV Enzyme
Activity Microplate Assay Kit, Abcam) or Pyruvate Dehydroge-
nase (Pyruvate dehydrogenase (PDH) Enzyme Activity Microplate
Assay Kit) activities were determined from mitochondrial extracts
using enzyme activity assays manufactured by Abcam.
Figure 7. Tissue-specific function of HIF1A during ALI. Hif1a
f/f Actin-Cre+ mice (A), Hif1a
f/f CadherinCre+ (B), Hif1a
f/f LysozymCre+ (C), Hif1a
f/f
ClaraCellCre+ (D), or Hif1a
f/f SurfactantCre+ (E) or corresponding age, weight, and gender-matched littermate controls (Cre expressing mice) were
exposed to ventilator-induced lung injury (VILI; pressure-controlled mechanical ventilation at an inspiratory pressure of 35 mbar with an inspired
oxygen concentration of 100%). Survival time was determined by measuring the time until a cardiac standstill was observed in the surface
electrocardiogram. Note significantly attenuated survival of Hif1a
f/f Actin-Cre+ mice or Hif1a
f/f SurfactantCre+ (A, E, mean 6 s.d., p,0.05, n=6).
Albumin concentration in the bronchoalveolar fluid was determined by enzyme-linked immunosorbent assay (ELISA; pressure-controlled mechanical
ventilation at an inspiratory pressure of 45 mbar with an inspired oxygen concentration of 100%, exposure time 180 min). Note significantly
increased albumin concentration in the bronchoalveolar fluid of Hif1a
f/f Actin-Cre+ mice or Hif1a
f/f SurfactantCre+ (A, E, mean 6 s.d., p,0.05, n=6).
doi:10.1371/journal.pbio.1001665.g007
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A549 cells were either grown on inserts or in 60-mm Petri
dishes. SMARTpool siRNA targeting SUCLG was synthesized by
Dharmacon (Lafayette, Colorado). SMART pool reagents com-
bine four SMART selection-designed siRNAs into a single pool,
resulting in even greater probability that the SMARTpool reagent
will reduce target mRNA to low levels. In addition, to further
increase transfection efficiency and off-target effects, siRNA was
selected by Dharmacon according ON-TARGETplus criteria. As
control, siRNA (Dharmacon, Lafayette, Colorado) with at least
four mismatches to any human, mouse, or rat gene was used.
A549 cell loading was accomplished using standard conditions of
DharmaFECT (Dharmacon, Lafayette, Colorado), when cells had
reached 40–60% confluence. After 48 h of loading, RNA/Protein
was isolated as described before [102].
Succinate-Mediated PHD Inhibition
Octyl-a-ketoglutarate as a stable, cell-permeable form of a-
ketoglutarate that accumulates rapidly and preferentially in cells
with a dysfunctional TCA cycle was used at 1 mM.
Pharmacological Inhibition of MAP Kinases
To inhibit MAP kinases in vitro, AMG 548 [Tocris, potent and
selective inhibitor of p38 (at 10 mM inhibits p38a, p38b, p38c, and
p38d)], FR 180204 [Tocris, selective ERK inhibitor (at 1 mM
inhibits ERK2 and ERK1)], and BI 78D3 [Tocris, competitive c-
Jun N-terminal kinase (JNK) inhibitor (500 nM)] was used.
TNFA and IL6 Neutralizing
For TNF-a neutralizing, D1B4 (Cell Signaling) Rabbit mAb
was used. For IL-6, anti-IL-6 antibody (ab6672) from abcam was
used.
ELISA (IL-6, IL-8, KC, TNF-a, MPO) from Cells, Lung Tissue,
or BAL
The snap-frozen lungs were thawed, weighed, and transferred
to different tubes on ice containing 1 ml of Tissue Protein
Extraction Reagent (T-PER; Pierce Biotechnology). Cells or lung
tissues were homogenized at 4uC. Cell or lung homogenates were
centrifuged at 9,000 g for 10 min at 4uC. Supernatants were
transferred to clean microcentrifuge tubes, frozen on dry ice, and
thawed on ice. Total protein concentrations in the lung tissue
homogenates were determined using a bicinchoninic acid kit
(Pierce Biotechnology). IL-6 (R&D Systems), IL-8 (R&D Systems),
KC (R&D Systems), TNF-a (R&D Systems), and MPO (Hycult
Biotech) levels were evaluated in lung tissue homogenates using a
mouse ELISA kit according to the user’s manual.
ATP Measurements
ATP from cells or tissue was determined using ATP Biolumi-
nescence Assay Kit CLS II for ATP Measurement from Roche.
ROS Measurements
Intracellular hydrogen peroxide levels were measured using an
Amplex Red Hydrogen Peroxide Assay kit (Molecular Probes/
Invitrogen) according to the manufacturer’s instructions. In brief,
total cell lysates and supernatants were harvested 24 h after stretch
in the FlexCell FX-4000T Tension Plus System. Lung tissue
exposed to VILI was homogenized in Tissue Protein Extraction
Reagent (T-PER; Pierce Biotechnology) and spun down at
13,000 g at 4uC for 10 min. Supernatants were collected and
used in the assay. Bronchoalveolar lavages from VILI exposed
animals were collected in 1 mL of saline. On a 96-well microplate,
samples were added and reactions were initiated immediately by
adding Amplex Red reaction mixture. Fluorescence was measured
on Synergy 2 Multi-Mode Microplate reader (BioTek) in
excitation range of 540/25 and emission detection of 620/40.
Fluorescence levels were normalized to the protein concentration.
Mice
Wild-type mice (BL6C57), Hif1a reporter mice (FVB.
129S6-Gt(ROSA)26Sor
tm2(HIF1A/luc)Kael/J) [63], Hif1a
f/f(B6.129-Hi-
f1atm3Rsjo/J), ActinCre+ (B6.Cg-Tg(CAG-cre/Esr1*)5Amc/J)
[103], CadherinCre+ (B6.Cg-Tg(Cdh5-cre)7Mlia/J) [104], SPC-
rtA (B6.Cg-Tg(SFTPC-rtTA)5Jaw/J) [105], and Tet-O-Cre
(B6.Cg-Tg(tetO-cre)1Jaw/J) [106] were purchased from Jackson
laboratories. Cre exclusively expressed in the conducting airway
(ClaraCellCre+) were obtained from Thomas Mariani [107]. To
obtain specific Hif1a
2/2 mice, Hif1a
f/f mice were crossed with the
appropriate Cre mouse. Whole body Hif1a
2/2 mice knockout
were achieved by a 5-d treatment of tamoxifen (1 mg/d) i.p. For
Hif1a tissue-specific knockout in the alveolar epithelium, triple
transgenic mice (Hif1a
f/f SPC-rtA Tet-O-Cre) were induced by
Doxycyclin therapy over 5 d i.p and p.o. as described [106].
Murine Mechanical Ventilation
All animal protocols were in accordance with the guidelines of
the National Institute for Health for the use of laboratory animals
and approved by the Institutional Animal Care and Use
Committee of the University of Colorado. Ventilator-induced
lung injury was induced as described previously [40].
BAL Lavage
To obtain BAL fluid, the tracheal tube was disconnected from
the mechanical ventilator and the lungs were lavaged 3 times with
0.5 ml of PBS. All removed fluid was centrifuged immediately,
Figure 8. Functional consequences of alveolar HIF1A deletion during ALI. (A–J) Hif1a
f/f SurfactantCre+ mice or age, gender, and weight-
matched littermate controls (SurfactantCre+) were exposed to ventilator-induced lung injury (VILI; pressure-controlled mechanical ventilation at an
inspiratory pressure of 45 mbar with an inspired oxygen concentration of 100%, exposure time 180 min). (A) Isolation of alveolar epithelial cells from
Hif1a
f/f SurfactantCre+ or control mice after VILI exposure. Frozen cells were lysed and proteins resolved by SDS-PAGE. Resultant Western blots were
probed with anti-Hif1a antibody. A representative blot of three is displayed. (B) Pulmonary neutrophil accumulation was quantified using
myeloperoxidase (MPO) ELISA. (C–E) IL-6, KC, or TNF-a, levels were evaluated in lung tissue homogenates using a mouse-enzyme-linked
immunosorbent assay (ELISA). Results are presented as mean 6 s.d. (n=6). (F) For quantification of histological tissue damage by ventilator-induced
lung injury following 180 min ventilation, VILI scores were assessed in Hif1a
f/f SurfactantCre+ or corresponding littermate control mice
(SurfactantCre+). Results are displayed as median and range (n=4). (G) One of four representative photomicrographs (6200) stained with
hematoxylin/eosin is displayed. (H–J) Hif1a
f/f SurfactantCre+ or matched controls (Surfactant Cre+) were treated with the pharmacologic HIF activator
dimethyl-oxaloylglycine DMOG (1 mg/mouse i.p. 4 h period to VILI) and subsequently exposed to VILI. (H) Albumin concentration in the
bronchoalveolar fluid by enzyme-linked immunosorbent assay (ELISA), (I) pulmonary gas exchange by the ratio of the arterial partial pressure of
oxygen (PaO2) to the fraction of inspired oxygen (FiO2), and (J) MPO activity by using a murine ELISA from lung tissue (mean 6 s.d.; n=6).
doi:10.1371/journal.pbio.1001665.g008
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albumin concentration.
Detecting Luciferase Expression in Vivo
Mice were given a single i.p. injection of a mixture of luciferin
(50 mg/kg) in sterile water. Following normal ventilation
(15 mbar, 3 h) or VILI (45 mbar, 3 h), lungs were immediately
excised and placed in a light-tight chamber equipped with a
charge-coupled device IVIS imaging camera (Xenogen, Alameda,
California). Photons were collected for a period of 5–20 s, and
images were obtained by using living image software (Xenogen)
and igor image analysis software (WaveMatrics, Lake Oswego,
Oregon).
Luciferase Assay—Tissue
Expression of the Hif1a reporter genes was assayed using the
tissue homogenates in Tper Tissue Protein Extraction Reagent
(Pierce). The homogenates were centrifuged for 30 min at
4,9006ga t4 uC. The luciferase gene expression was measured
by using the Dual-Luciferase Reporter Assay System from
Promega according to the manufacturer’s instructions using a
Biotek Synergy 2 Multimode Microplate Reader.
Pharmacolgical Studies in Vitro and in Vivo
Rotenone (Tocris), 2-Deoxy-D-glucose (2-DG), Dimethyloxa-
lylglycine (DMOG), and Echinomycin were purchased from
Sigma-Aldrich, USA and used at the concentrations as indicated.
Isolation of Murine Alveolar Epithelial Cells
Following 4 h of VILI, mice were euthanized by pentobarbital
overdose. Lungs were lavaged with sterile PBS, then perfused with
PBS via the right ventricle. As previously described, dispase (BD,
USA) was instilled followed by a low-melting point agarose plug.
Lungs were removed intact and incubated at 37uC for 30 min.
Tissue was dissociated manually and cells progressively filtered
(70 mm/40 mm, Fisher, USA). Cells were treated with FcR
blocking mAB (24G2) and labeled with anti-EpCAM biotin
(eBioscience, USA) and anti-biotin Dylight 633. EpCAM positive
cells were positively selected using streptavidin magnetic microbe-
ads (Miltenyi, USA). Purified cells were analyzed for EpCAM
expression using a LSRII flow cytometer (BD, USA) and FlowJo
v8.8.4 software (TreeStar, USA) [108].
Histopathological Evaluation of ALI
Following ventilation at the settings indicated in the figure
legends, the mice were euthanized and lungs were fixed by
instillation of 10% formaldehyde solution via the tracheal cannula
at a pressure of 20 mbar. Lungs were then embedded in paraffin
and stained with hematoxylin and eosin. Two random tissue
sections from four different lungs in each group were examined by
a pathologist who was blinded to the genetic background and
treatment of the mice. For each subject, a 5-point scale was
applied: 0, minimal damage; 1 to .2, mild damage; 2 to .3,
moderate damage; 3 to .4, severe damage; and 4+, maximal
damage. Points were added together and are expressed as median
6 range (n=4).
Metabolite Analysis by UPLC-MS
Hif1a
f/f SPC-rtA Tet-O-Cre mice or littermate controls
(induced SPC-rtA Tet-O-Cre mice) matched in age, weight, and
gender were exposed to 2 h of VILI [45 mbar].
13C-glucose was
administered 30 min prior to the onset of VILI via intraperitoneal
injection. Lung tissue was snap-frozen with clamps pre-cooled to
the temperature of liquid nitrogen. Seven metabolites (glucose,
lactate, pyruvate, malate, fructose-1,6-bisphosphate, glutamate,
and creatine) were measured by ultrahigh performance liquid
chromatography–mass spectrometry (UPLC-MS) using a Waters
Acquity ultrahigh-performance liquid chromatograph coupled to a
Waters Synapt HDMS quadrupole time-of-flight mass spectrom-
eter, which was operated with an atmospheric pressure electro-
spray ionization (ESI) source as described previously.[32]
Data Analysis
Data were compared by two-factor ANOVA with Bonferroni’s
posttest or by Student’s t test where appropriate. Values are
expressed as mean 6 s.d. from 3–6 animals per condition. For
analysis of changes in transcript, a one-way ANOVA was carried
out and multiple comparisons between control and treatment
groups were made using the Dunnett posttest. The Mantel Cox
test was used for analysis of survival curves. Data are expressed as
mean 6 s.d.; p,0.05 was considered statistically significant. For all
statistical analyses, GraphPad Prism 5.0 software for Windows XP
was used. The authors had full access to and take full responsibility
for the integrity of the data. All authors have read and agree to the
manuscript as written.
Supporting Information
Figure S1 Pathway analysis. Human alveolar epithelial cells
(Calu-3) were exposed to stretch conditions as an in vitro model for
ventilator-induced ALI (24 h stretch at 30% intensity (http://www.
ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE27128).
Computerized pathway analyses to examine alterations in gene
transcription (Ingenuity IPA, Version 11631407) shows that
hypoxia-signaling resembled the dominant stress response
pathway when comparing stretch-exposed pulmonary epithelia
to un-stretched controls.
(TIFF)
Figure 9. Functional role of alveolar epithelial HIF1A on glycolysis during ALI. (A–D) Hif1a
f/f SurfactantCre+ mice or littermate controls
(SurfactantCre+) matched in age, weight, and gender were exposed to ventilator-induced lung injury (VILI; pressure-controlled mechanical ventilation
at an inspiratory pressure of 45 mbar with an inspired oxygen concentration of 100%, exposure time 120 min).
13C glucose was administered i.p.
30 min prior to the experimental procedure. Determination of
13C glucose and
13C carbohydrates during VILI was performed using liquid
chromatography–tandem mass spectrometry (LC-MS). Glut 1 transcript level was determined by real-time RT-PCR relative to house-keeping gene
beta-actin and expressed as fold induction relative to sham-operated controls (mean 6 SD, n=3). (A)
13C glucose. (B) Glut-1 transcript levels. (C)
13C
fructose 1,6 bisphosphate. (D)
13C lactate. (E–H) To examine the functional role of glycolysis, wild-type mice treated with the glycolysis inhibitor 2-
deoxy-D-glucose (200 mg/kg dose, i.p.) 30 min prior to the experimental procedure, and subsequently exposed to VILI (see above). Albumin
concentration in the bronchoalveolar fluid (E) by enzyme-linked immunosorbent assay (ELISA), pulmonary gas exchange (F) by the ratio of the arterial
partial pressure of oxygen (PaO2) to the fraction of inspired oxygen (FiO2), and MPO activity by using a murine ELISA from lung tissue (G) or IL-6 levels
(H) in lung tissue homogenates using a mouse enzyme-linked immunosorbent assay (ELISA). Results are presented as mean 6 s.d. (n=6). (I and J)
Mechanical ventilation was instituted and SurfactantCre+ controls or Hif1a
f/f SurfactantCre+ mice with and without 2-DG treatment were exposed to
VILI (pressure-controlled mechanical ventilation at an inspiratory pressure of 35 mbar with an inspired oxygen concentration of 100%) until a cardiac
standstill was observed in the surface electrocardiogram (p,0.05, n=6).
doi:10.1371/journal.pbio.1001665.g009
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C) Stable cell cultures with decreased HIF1A or HIF2A expression
were generated by lentiviral-mediated shRNA expression. For
controls, nontargeting control shRNA was used. Cells were co-
transfected with pLK0.1 vectors and packaging plasmids to
produce lentivirus. Filtered supernatants were used for infection
of Calu-3 and cells were selected with puromycin (30 mg/ml) for
at least two passages before initiating stretch experiments. RT
PCR or Western blot for HIF1A or HIF2A revealed a 98%
reduction of transcript or protein, respectively.
(TIFF)
Figure S3 In vitro studies in HIF1A or HIF2A knock-
down Calu-3 cells. (A) Transcript levels of glycolytic enzymes
from HIF1A KD Calu-3 pulmonary epithelia (lentivirus-mediated
HIF1A knockdown) or Calu-3 epithelia transduced with a control
virus (lentiviral scrambled siRNA, Scr) after 24 h of stretch were
determined by real-time RT-PCR relative to housekeeping gene
beta-actin (mean 6 s.d., n=3). (B–D) Calu-3 controls or Calu-3
HIF2KD were exposed to 24 h of stretch. (B) Levels of glycolytic
enzymes after 24 h of stretch were determined by real-time RT-
PCR relative to Actb (mean 6 SD, n=3). (C) Lactate levels in
supernatants obtained from Calu-3 with a lentiviral-mediated
HIF2A KD after 24 h of stretch. Controls consisted of Calu-3 cells
treated with lentiviral scrambled siRNA exposed to the same
experimental conditions. (D) IL-6 and IL-8 levels were evaluated
in supernatants from stretched Calu-3 controls or Calu-3 HIF2KD
exposed to 24 h of stretch using a human enzyme-linked
immunosorbent assay (ELISA). Results are presented as mean 6
s.d. (n=4, unless stated otherwise).
(TIFF)
Figure S4 In vivo studies on pharmacological or genetic
HIF1A inhibition. (A) Mice were treated with 1 mg of DMOG
Figure 10. Consequences of alveolar-epithelial Hif1a deletion on mitochondrial function during ALI. (A–G) Hif1a
f/f SurfactantCre+ mice
or littermate controls (SurfactantCre+) matched in age, weight, and gender were exposed to ventilator-induced lung injury (VILI; pressure-controlled
mechanical ventilation at an inspiratory pressure of 45 mbar with an inspired oxygen concentration of 100%, exposure time 120 min).
13C glucose
was administered i.p. 30 min prior to the experimental procedure. Determination of
13C carbohydrates during VILI was performed using liquid
chromatography–tandem mass spectrometry (LC-MS). (A)
13C malate. (B) Tricarboxylic acid (TCA) cycle flux rates were determined by measuring the
ratio of
13C2 glutamate to total creatine (n=4 for all experiments). (C–F) Hif1a
f/f SurfactantCre+ mice or age-, gender-, and weight-matched littermate
controls (SurfactantCre+) were exposed to VILI (see above). (C) After 3 h of VILI exposure, mitochondrial fractions were obtained from lung tissue and
analyzed for Complex IV activity using ELISA. Activity is given as OD (optical density) change over time (mean 6 s.d., n=3). (D) Frozen lung tissue was
lysed and mitochondrial proteins resolved by SDS-PAGE. Resultant Western blots were probed with anti-COX4-2 antibody. A representative blot of
three is shown. (E) Pulmonary ATP content in Hif1a
f/f SurfactantCre+ mice or littermate controls (SurfactantCre+) were exposed to VILI (inspired
oxygen concentration 100%, exposure time 120 min, pressure-controlled ventilation with an inspiratory pressure of 45 mbar). (F) Hydrogen peroxide
lung tissue levels in Hif1a
f/f SurfactantCre+ mice or littermate controls (SurfactantCre+) exposed to VILI. Data are expressed as the mean fluorescence
levels from three independent experiments normalized by protein concentration. Error bars represent s.d. (n=3). (G and H) BL6C57 mice were treated
with Rotenone—an inhibitor of mitochondrial respiration—or vehicle control 1 h prior to the beginning of the experimental procedure. IL-6 levels in
lung tissue homogenates (G) or Albumin levels in BAL (H) were evaluated using a mouse enzyme-linked immunosorbent assay (ELISA) following
exposure to VILI (see above). Results are presented as mean 6 s.d. (n=6).
doi:10.1371/journal.pbio.1001665.g010
Figure 11. Proposed model of ALI-associated HIF1A stabilization. (1) During ALI, stretch of pulmonary epithelial cells results in the inhibition
of succinate dehydrogenase (SDH), leading to normoxic stabilization of alveolar epithelial HIF1A. (2) Alveolar epithelial HIF1A results in increased
glycolytic capacity, TCA flux, and optimized mitochondrial respiration via induction of Complex IV. (3) HIF1A-dependent prevention of mitochondrial
dysfunction during ALI is associated with increased alveolar epithelial capacity to produce ATP, while concomitantly preventing ROS accumulation
and attenuating lung inflammation.
doi:10.1371/journal.pbio.1001665.g011
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Resultant Western blots were probed with anti-Hif1a antibody.
To control for loading conditions, blots were stripped and re-
probed for actin expression. A representative experiment of three
is shown. (B) WT mice were exposed to 3 h of VILI with and
without Echinomycin pretreatment. Echinomycin blocks the
transcriptional binding site of Hif1a. Levels of glycolytic enzymes
were determined by real-time RT-PCR relative to Actb and
expressed as fold induction relative to sham-operated controls
(mean 6 SD, n=3). (C) DMOG treatment (1 mg i.p.) in mice with
induced deletion of Hif1a in all tissues, including the lungs
(Hif1af/f ActinCre+, whole body knockout mice). Lungs were
harvested at indicated time points and Western blots were probed
with anti-Hif1a antibody. A representative experiment of three is
shown.
(TIFF)
Figure S5 HIF1A immunohistochemistry. Hif1a immuno-
histochemistry is shown for untreated wild-type (WT, left side)
compared to cell-type-specific Hif1a knock-out tissue (right side)
including (A) lung endothelium, (B) bronchial epithelium, and (C)
alveolar cells. (A) Untreated WT lung endothelium (left) display
several nuclei with considerable HIF1a immunopositivity (black
arrows). Even after DMOG treatment, lung endothelial cells (black
arrows) of Hif1a
f/fCadherinCre+ animals (right) showed no Hif1a
expression confirming the good quality of the knock-out. (B and C)
Similar findings were obtained for bronchial epithelia (B, black
arrows) and alveolar cells (C, black arrows) showing moderate
Hif1a expression in WT animals (left) but absence in correspond-
ing cell-type-specific Hif1a knock-out mice after DMOG treat-
ment. (A–C) Inflammatory cells in cell-type-specific Hif1a knock-
out animals, infiltrating inflammatory cells (red arrows) served as
internal positive control still exhibiting Hif1a expression. (Original
magnification 406for all images.)
(TIFF)
Figure S6 Purified alveolar epithelial cells show re-
duced HIF1A expression in conditional knockout follow-
ing VILI. Conditional knockout mice (experimental/E) have a
loxP-flanked Hif1a, a SPC-rtTA, and TetO-Cre-recombinase
transgene. Littermate controls (control/C) lack the tetO-Cre
transgene. (A) Purification of alveolar epithelia cells (AECs) from
control and experimental animals: cells are highly enriched for
expression of EpCAM (epithelial cell adhesion molecule) indicat-
ing purity of AECs. (B) Purified AECs show Cre-recombinase
activity and absence of floxed Hif1a gene (red box) in experimental
animals determined by conventional PCR using standard
genotyping protocols (Jackson Laboratory, by GeneTyper–Mouse
Genotyping Service).
(TIFF)
Figure S7 Consequences of glycolysis inhibition during
ALI. (A) Transcript levels of phosphofructokinase-m (Pfkm),
pyruvate dehydrogenase kinase 1 (Pdk1), and lactate dehydroge-
nase a (Ldha) from controls (SurfactantCre+) or Hif1af/f
SurfactantCre+ mice after 180 min at 45 mbar mechanical
ventilation (mean 6 s.d., n=3). (B) Hydrogen peroxide levels of
BAL from Hif1a
f/f SurfactantCre+ mice or age-, gender-, and
weight-matched littermate controls (SurfactantCre+) with or
without 2-DG treatment. The data are expressed as the mean
fluorescence levels from two independent experiments normalized
by protein concentration (ELISA). Results are presented as mean
6 s.d. (n=4, unless stated otherwise).
(TIFF)
Figure S8 Functional consequences of HIF1A activation
during ALI in CD73 deficient mice. (A) HIF1A activator
dimethyl-oxaloylglycine (DMOG) during ALI: BL6C57 or
CD732/2 mice were treated with 1 mg DMOG or vehicle
control 4 h prior to the experimental procedure. Mechanical
ventilation was instituted and mice were ventilated for 180 min
using pressure-controlled settings (inspiratory pressure of 45 mbar,
100% inspired oxygen concentration). Albumin concentration in
the bronchoalveolar fluid (BAL) was determined by enzyme-linked
immunosorbent assay. Results are presented as mean 6 s.d.
(n=6).
(TIFF)
Table S1 Microarray analysis. Human alveolar epithelial
cells (Calu-3) were exposed to stretch conditions as an in vitro
model for ventilator-induced ALI (24 h stretch at 30%
intensity; http://www.ncbi.nlm.nih.gov/projects/geo/query/
acc.cgi?acc=GSE27128). A subset of HIF1A-dependent genes
were confirmed utilizing real-time RT-PCR and Western
blotting. Significant changes ing e n ee x p r e s s i o na r ed i s p l a y e d
as fold change (p,0.05). Confirmation by real-time RT-PCR
and Western blotting (unpublished data).
(XLSX)
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